UPC Universe Pharmaceuticals Inc.
Healthcare$2.61-10.15%ClosedMarket Cap: $1.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.03
P/S
0.09
EV/EBITDA
7.77
DCF Value
$7,060.61
FCF Yield
-327.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
35.3%
Operating Margin
-16.3%
Net Margin
-20.6%
ROE
-6.6%
ROA
-5.3%
ROIC
-4.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $8.7M | 36.0% | $-589.2K | $-387.3K | $— | — |
| FY null | $17.9M | 35.3% | $-2.9M | $-3.7M | $— | — |
| Q2 null | $9.2M | 34.6% | $-2.3M | $-3.3M | $— | — |
| Q4 null | $10.1M | 27.9% | $-6.3M | $4.4M | $— | — |
| FY null | $23.0M | 26.4% | $-8.0M | $-8.7M | $— | — |
| Q2 null | $12.9M | 25.2% | $-1.7M | $-13.1M | $— | — |
| Q4 null | $13.8M | 29.4% | $-3.7M | $-5.4M | $— | — |
| FY null | $32.3M | 31.9% | $-3.5M | $-6.2M | $— | — |
| Q2 null | $18.5M | 32.6% | $149.3K | $-715.4K | $— | — |
| Q4 null | $15.9M | 50.5% | $-10.1M | $-10.5M | $— | — |
| FY null | $40.1M | 54.5% | $-7.0M | $-8.7M | $— | — |
| Q2 null | $24.2M | 56.3% | $2.7M | $1.7M | $— | — |